| abstract |
The present application relates to compounds of formula (I) as defined herein which are MALT1 inhibitors, and to pharmaceutically acceptable salts thereof. The present application also provides pharmaceutical compositions comprising a compound of formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases such as cancer, autoimmune disorders, and inflammatory disorders. Write it down. |